Literature DB >> 11803476

Expression of multiple forms of clusterin during light-induced retinal degeneration.

P Wong1, T Ulyanova, D T Organisciak, S Bennett, J Lakins, J M Arnold, R K Kutty, M Tenniswood, T vanVeen, R M Darrow, G Chader.   

Abstract

PURPOSE: Clusterin has been associated with active cell death in several different model systems, including animal models of retinal degeneration. Clusterin is also expressed in normal tissues, a finding that leads to the question of how it could then play a cell death-specific role during tissue regression. To address this paradox, we have examined clusterin expression during light-induced retinal damage in rats.
METHODS: Normal albino rats were reared in darkness and then exposed to intense visible light to induce retinal degeneration. Clusterin expression was then examined at various times after light treatment. Standard molecular techniques including Northern analysis, immunohistochemistry, and Western analysis were employed.
RESULTS: Northern analysis established that the largest increase in clusterin expression occurs after a decrease in interphotoreceptor retinoid binding protein, IRBP, expression (an indication of a photoreceptor cell dysfunction) and after an increase in heme oxygenase 1, HO-1, expression (an oxidative stress inducible gene), suggesting that induction of clusterin expression is an oxidative stress response. Immuno-histochemical analysis with two different clusterin-specific antibodies, anti(SGP-2) and anti(301), localized distinct forms of clusterin to Müller cells and degenerating photo-receptor cells. Western analysis demonstrated degeneration associated isoforms of clusterin in light treated retina that are not present in normal retina.
CONCLUSION: Clusterin over-expression is characteristic of a retinal degeneration phenotype and we propose that clusterin action may be defined by the nature in which it is modified. We hypothesize that alternate processing leads to retinal degeneration-specific forms of the protein (65, 61, and 50 kDa) that are not present in normal retina.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11803476     DOI: 10.1076/ceyr.23.3.157.5463

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  13 in total

1.  Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.

Authors:  Chengjian Tu; Kay D Beharry; Xiaomeng Shen; Jun Li; Lianshui Wang; Jacob V Aranda; Jun Qu
Journal:  J Proteome Res       Date:  2015-04-06       Impact factor: 4.466

2.  Mutation screen of the cone-specific gene, CLUL1, in 376 patients with age-related macular degeneration.

Authors:  Gwen M Sturgill; Gayle J T Pauer; Elisa Bala; Ellen Simpson; Stacia S Yaniglos; John W Crabb; Joe G Hollyfield; Hilel Lewis; Neal S Peachey; Stephanie A Hagstrom
Journal:  Ophthalmic Genet       Date:  2006-12       Impact factor: 1.803

3.  Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.

Authors:  Dan Xie; Jonathan-S-T Sham; Wei-Fen Zeng; Li-Hong Che; Meng Zhang; Hui-Xi Wu; Han-Liang Lin; Jian-Ming Wen; Sze-Hang Lau; Liang Hu; Xin-Yuan Guan
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

4.  Temporal changes in gene expression after injury in the rat retina.

Authors:  Félix Vázquez-Chona; Bong K Song; Eldon E Geisert
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

5.  Ocular clusterin expression in von Hippel-Lindau disease.

Authors:  Min Zhou; Defen Shen; James E Head; Emily Y Chew; Patricia Chévez-Barrios; W Richard Green; Chi-Chao Chan
Journal:  Mol Vis       Date:  2007-11-15       Impact factor: 2.367

6.  Clusterin expression in non-neoplastic adenohypophyses and pituitary adenomas: cytoplasmic clusterin localization in adenohypophysis is related to aging.

Authors:  A Işin Doğan Ekici; Bülent Eren; Nursel Türkmen; Nil Comunoğlu; Recep Fedakar
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.

Authors:  Sahar M Hazzaa; Osama M Elashry; Ibtesam K Afifi
Journal:  Pathol Oncol Res       Date:  2009-09-09       Impact factor: 3.201

8.  Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer.

Authors:  Marwa I Shabayek; Ola M Sayed; Hanan A Attaia; Heba A Awida; Hamdy Abozeed
Journal:  Pathol Oncol Res       Date:  2014-04-03       Impact factor: 3.201

9.  Retinal Pre-Conditioning by CD59a Knockout Protects against Light-Induced Photoreceptor Degeneration.

Authors:  Delu Song; Brooks Wilson; Liangliang Zhao; Rupak Bhuyan; Mausumi Bandyopadhyay; Arkady Lyubarsky; Chen Yu; Yafeng Li; Levi Kanu; Takashi Miwa; Wen-Chao Song; Silvia C Finnemann; Bärbel Rohrer; Joshua L Dunaief
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

10.  Clusterin: full-length protein and one of its chains show opposing effects on cellular lipid accumulation.

Authors:  Suvarsha Rao Matukumalli; Ramakrishna Tangirala; C M Rao
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.